Livongo just went public after raising over $350 million in its IPO
Livongo has been launched in 2014 and emerged from a previous company called EosHealth, invested in by its founder Glen Tullman’s VC firm 7wire Ventures.
The company began by focusing on diabetes but has since moved into other disease areas, including hypertension and mental health.
Today going public is really a branding event and we deal with 20 percent of the Fortune 500. Those organizations like to see that we’re stable and they like the transparency of public companies, Tullman said in an interview on CNBC. We also wanted to make sure we had a currency to use for acquisitions as we grow our whole person platform to serve more and more people with chronic conditions.